CG Oncology, Inc.(CGON)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
CGON has no upcoming report date in the calendar yet. It last reported on Nov 6, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±5.7%).
Did the stock rise after good news?
The next-day move after each of its last 4 EPS beats and 7 misses.
In plain words: it beat expectations 4 times, but the stock still fell 1 of those 4 times.
- Nov '26Beat▲ +17.3%
- Aug '26Missed▲ +3.4%
- May '26Missed▲ +0.6%
- Feb '26Beat▲ +4.8%
- Nov '25Missed▲ +8.6%
- Aug '25Missed▲ +2.1%
- May '25Missed▼ -3.9%
- Nov '24Beat▼ -6.8%
- Aug '24Beat▲ +7.0%
- May '24Missed▼ -7.4%
- Mar '24Missed▲ +0.3%
Clear beats and misses with a known reaction only. What counts as a beat
Why did CGON fall after beating earnings?
6 of CGON's last 11 reactions went against the EPS result. What stands out in each:
CGON beat EPS estimates in 4 quarters, and the stock still closed lower the next day 1 time.
- Nov 12, 2024EPS beat +11.8%stock -6.8% next day
- It had risen 5.8% in the 20 trading sessions before the report, so good news may already have been priced in.
Rose despite an EPS miss (5 of 7)
- Aug 6, 2026EPS missed -40.6%stock +3.4% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- May 8, 2026EPS missed -31.5%stock +0.6% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 14, 2025EPS missed -3.6%stock +8.6% next day
- It had already fallen 9.8% in the 20 trading sessions before the report, so weak results may have been expected.
- Aug 8, 2025EPS missed -20.0%stock +2.1% next day
- It had already fallen 10.2% in the 20 trading sessions before the report, so weak results may have been expected.
- Mar 26, 2024EPS missed -1342.0%stock +0.3% next day
- It had already fallen 11.4% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was CGON's earnings move already priced in?
CGON's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
CGON earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Before open | -$0.81 | -$0.64 | +21.0% | +225.9% | +17.27% | — |
| Aug 6, 2026 | Before open | -$0.64 | -$0.90 | -40.6% | — | +3.36% | +5.72% |
| May 8, 2026 | Before open | -$0.54 | -$0.71 | -31.5% | — | +0.64% | +4.18% |
| Feb 27, 2026 | Before open | -$0.58 | -$0.51 | +12.1% | — | +4.79% | +7.91% |
| Nov 14, 2025 | Before open | -$0.55 | -$0.57 | -3.6% | — | +8.61% | +12.69% |
| Aug 8, 2025 | Before open | -$0.45 | -$0.54 | -20.0% | — | +2.05% | +2.46% |
| May 13, 2025 | Before open | -$0.37 | -$0.45 | -21.6% | — | -3.90% | +0.76% |
| Mar 28, 2025 | Before open | -$0.46 | -$0.48 | -4.3% | — | — | — |
| Nov 12, 2024 | Before open | -$0.34 | -$0.30 | +11.8% | — | -6.83% | -10.56% |
| Aug 8, 2024 | Before open | -$0.31 | -$0.28 | +9.7% | — | +7.02% | +5.92% |
| May 9, 2024 | Before open | -$0.15 | -$0.36 | -140.0% | — | -7.43% | -20.32% |
| Mar 26, 2024 | Before open | -$1.00 | -$14.42 | -1342.0% | — | +0.27% | +7.70% |
CGON Earnings FAQ
Answers computed from CG Oncology, Inc.'s reported history
CGON has no upcoming report date in the calendar yet. It last reported on Nov 6, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, CGON beat the consensus estimate 4 times (33%), missed 8 and landed in line 0.
Across its last 11 quarters with a measured reaction, CGON moved an average of ±5.7% in the first session after reporting. It closed higher 73% of the time; the largest gain was 17.3% and the largest drop -7.4%.
CGON fell in the first session after 1 of its last 4 EPS beats (25%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 11 quarters with price data, CGON moved an average of -0.4% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -0.6%. After a drop of 3% or more (5 quarters), it rose the next day 80% of the time, averaging +2.1%. This describes past reports; it is not a forecast.
How we calculate these numbers · CGON: 12 reported quarters, latest Nov 6, 2026. Information only, not investment advice.
Looking for more on CGON?
Price charts, forecast, fundamentals and risk pages for CGON are not on Tickzen yet. You can run a full stock analysis now.
Run the CGON Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun